Padsevonil    (DrugBank: Padsevonil)

1 disease
IDDisease name (Link within this page)Number of trials
149Hemiconvulsion hemiplegia epilepsy syndrome1

149. Hemiconvulsion hemiplegia epilepsy syndrome    [ 22 clinical trials,   33 drugs,   (DrugBank: 12 drugs),   13 drug target genes,   17 drug target pathways]
Searched query = "Hemiconvulsion hemiplegia epilepsy syndrome", "One side convulsions", "Hemiplegia", "Epilepsy syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 22 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-JapicCTI-194958
01/10/201918/09/2019A pharmacokinetic, safety, and tolerability study of padsevonil in CYP2C19 genotyped healthy male Japanese study participants.An Open-Label, Parallel Group, Single-Center Study to Investigate the Pharmacokinetic, Safety, and Tolerability Profiles of Padsevonil in CYP2C19 Genotyped Healthy Male Japanese Study Participants Epilepsy and epilepsy syndromeIntervention name : padsevonil
INN of the intervention : padsevonil
Dosage And administration of the intervention : Oral administration
Control intervention name : -
INN of the control intervention : -
Dosage And administration of the control intervention : -
UCB Japan Co., Ltd.NULLcomplete2055Male39Phase 1Japan